|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 13.40 USD | -1.25% |
|
-1.83% | -36.22% |
| 10-13 | Top Midday Decliners | MT |
| 10-13 | Syndax Pharmaceuticals Selloff After IPF Trial Failure Appears 'Overdone,' BofA Securities Says | MT |
| Market Cap | 1.2B 1.07B 986M 895M 1.68B 114B 1.7B 11.87B 4.7B 59.46B 4.49B 4.39B 188B | P/E 2026 * |
-6.63x | P/E 2027 * | -16x |
|---|---|---|---|---|---|
| Enterprise Value | 1.55B 1.38B 1.28B 1.16B 2.17B 147B 2.21B 15.39B 6.09B 77.08B 5.82B 5.7B 243B | EV / Sales 2026 * |
4.94x | EV / Sales 2027 * | 3.38x |
| Free-Float |
98.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNDX | Delayed | |
CBOE
| SNDX | Real-time | |
Tradegate
| 1T3 | Real-time | |
Deutsche Boerse AG
| 1T3 | Delayed | |
Börse Stuttgart
| 1T3 | Delayed | |
Boerse Muenchen
| 1T3 | Real-time |
Last Transcript: Syndax Pharmaceuticals, Inc.
| 1 day | -1.25% | ||
| 1 week | -1.83% | ||
| Current month | -28.72% | ||
| 1 month | -26.31% | ||
| 3 months | -39.23% | ||
| 6 months | -39.31% | ||
| Current year | -36.22% |
| 1 week | 12.8 | 13.61 | |
| 1 month | 12.8 | 18.94 | |
| Current year | 12.8 | 25.59 | |
| 1 year | 12.8 | 25.59 | |
| 3 years | 8.58 | 25.59 | |
| 5 years | 8.58 | 29.86 | |
| 10 years | 3.39 | 29.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 55 | 2022-02-02 |
Peter Ordentlich
CTO | Chief Tech/Sci/R&D Officer | 57 | 2013-10-31 |
Keith Goldan
DFI | Director of Finance/CFO | 55 | 2022-06-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Podlesak
CHM | Chairman | 68 | 2008-11-30 |
Michael Metzger
BRD | Director/Board Member | 55 | 2019-07-03 |
Pierre Legault
BRD | Director/Board Member | 65 | 2017-01-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/8/26 | Exercice | Chief Executive Officer | 97,125 | 0.1096% | ||
| 6/1/26 | Sell | Chief Financial Officer | -1,177 | 0.0013% | ||
| 6/1/26 | Sell | Chief Executive Officer | -6,847 | 0.0077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.25% | -1.83% | -11.32% | +16.42% | 1.17B | ||
| +2.41% | -6.33% | +43.43% | +71.02% | 63.29B | ||
| -0.15% | +3.11% | +10.29% | +72.56% | 54.89B | ||
| +0.57% | +4.64% | +12.82% | +89.79% | 53.28B | ||
| +0.37% | +3.07% | +28.23% | +51.53% | 45.81B | ||
| -1.21% | +0.95% | +20.44% | +128.58% | 43.46B | ||
| -0.37% | -1.20% | +252.94% | +568.54% | 40.23B | ||
| +0.05% | +6.75% | +14.48% | +56.75% | 33.45B | ||
| +1.19% | -5.84% | +27.86% | -0.65% | 23.7B | ||
| -0.38% | +4.55% | +37.71% | +28.10% | 23.76B | ||
| Average | +0.12% | +0.23% | +43.69% | +108.26% | 38.31B | |
| Weighted average by Cap. | +0.37% | +0.55% | +47.99% | +121.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 314M 280M 259M 235M 440M 29.82B 447M 3.12B 1.23B 15.61B 1.18B 1.15B 49.26B | 459M 410M 378M 343M 643M 43.58B 653M 4.56B 1.8B 22.81B 1.72B 1.69B 72B |
| Net income | -180M -161M -148M -135M -252M -17.09B -256M -1.79B -707M -8.94B -675M -661M -28.22B | -77.54M -69.22M -63.9M -57.98M -109M -7.36B -110M -769M -304M -3.85B -291M -285M -12.16B |
| Net Debt | 355M 317M 292M 265M 497M 33.67B 504M 3.52B 1.39B 17.62B 1.33B 1.3B 55.62B | 356M 318M 293M 266M 498M 33.76B 506M 3.53B 1.4B 17.67B 1.33B 1.31B 55.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$13.40 | -1.25% | 4,246,400 |
| 26-10-22 | US$13.57 | +3.19% | 2,362,751 |
| 26-10-21 | US$13.15 | -0.75% | 2,587,704 |
| 26-10-20 | US$13.25 | +1.22% | 3,912,542 |
| 26-10-19 | US$13.09 | +1.47% | 2,192,507 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDX Stock
Select your edition
All financial news and data tailored to specific country editions

















